Boston, MA · Founded 2022 · Privately Held (backing)
Operator of a biologics platform intended to enable targeted cancer treatment using tumor-specific biochemical markers. Crosslink Therapeutics is based in Boston, MA and was founded in 2022. It has raised $8 million across 1 recorded round; the latest was a $4.3 million seed round in Apr 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$8.0M
Last round
Seed Round
Apr 2025
Team — not yet on record
No current team members for Crosslink Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Crosslink Therapeutics with a free account
·Watch Crosslink Therapeutics: the Monday email on marks, rounds and moves
